“…In conclusion, the results of our retrospective analysis provide convincing support to the suggestion that aerosols released by patients infected by SARS-CoV-2 Omicron variant may contain higher viral particles than those released by subjects infected with previous SARS-CoV-2 strains, thus providing a solid biologic background to justify enhanced transmissibility of this new linage and higher prevalence of upper respiratory tract symptoms reported in other studies [ 3 , 4 ].…”